Venus Remedies has informed that it has been awarded with Rs 2.50 crore under the Production Linked Incentive (PLI) scheme, which covers balance 25% of the total incentive of Rs.10.00 crores. The initial disbursement of Rs 7.50 crore was awarded by the Central Government earlier this month. Following the latest disbursement, the company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme. This incentive further strengthens its commitment to innovation and excellence in pharmaceutical manufacturing.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: